Presentation TCT 2013 Platelet Function Testing is of Clear Clinical Utility in Selected Patients Presenter: Paul Gurbel October 31, 2013
Presentation TCT 2013 The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice Presenter: Dean Kereiakes October 31, 2013
Presentation TCT 2013 Genetic Testing is of Clear Clinical Utility in Selected Patients Presenter: Jessica Mega October 31, 2013
Presentation TCT 2013 Critical Appraisal and Clinical Implications(3) Presenter: Dean Kereiakes October 31, 2013
News Conference News TCT 2013 Studies Find Differing Benefits of Platelet, Genotype Testing October 31, 2013
Presentation TCT 2013 EUROMAX: Critical Appraisal and Clinical Implications Presenter: Gregg Stone October 30, 2013
Presentation TCT 2013 The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards Presenter: Roxana Mehran October 30, 2013
Presentation TCT 2013 Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy Presenter: Krishna Rocha-Singh October 30, 2013
News Conference News TCT 2013 Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions October 30, 2013
News Conference News TCT 2013 Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology October 30, 2013
News Conference News TCT 2013 EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI October 30, 2013
News Conference News TCT 2013 Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients October 30, 2013
News Conference News TCT 2013 Renal Denervation Systems Show Persistent Reductions in BP October 30, 2013
Presentation TCT 2013 Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation Presenter: Dmitriy Feldman October 28, 2013
News Conference News TCT 2013 Renal Denervation for Moderate Treatment-Resistant Hypertension Explored October 28, 2013